Company news
Delcath Systems, Inc. news in 2023
Delcath Systems, Inc.'s news releases, calls and decks from 2023, newest first.
Delcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 14, 2023
Delcath Systems Reports Third Quarter 2023 Results and Provides Business Update
November 12, 2023
Delcath Systems Announces a Comparative Study of Chemosat and SIRT Published in the Journal Cancers
October 15, 2023
Delcath Systems, Inc. Announces Additional $35 Million in Funding Tied to the FDA Approval of HEPZATO KIT™
August 31, 2023
Delcath Systems, Inc. Announces FDA Approval of HEPZATO KIT™ for the Treatment of Adult Patients with Unresectable Hepatic-Dominant Metastatic Uveal Melanoma
August 13, 2023
Delcath Systems Reports Second Quarter 2023 Results and Provides Business Update
August 8, 2023
Delcath Systems Appoints Vojislav Vukovic as Chief Medical Officer
June 19, 2023
Delcath Systems Announces Sandra Pennell as Senior Vice President of Finance
June 6, 2023
Delcath Systems Provides Business Update and Reports Preliminary First Quarter 2023 Financial Results
May 11, 2023
Delcath Systems Announces Resumption of Interest-Only Period for Company's Debt Facility
April 2, 2023
Delcath Systems Announces Closing of Private Placement of up to $85 Million
March 28, 2023
Delcath Systems Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update
March 26, 2023
Delcath Systems, Inc. Announces FDA Acceptance of New Drug Application Resubmission of Hepzato Kit with a PDUFA Date of August 14, 2023
March 26, 2023
Delcath Systems Announces up to $85 Million Financing
March 26, 2023
Delcath Announces Rotation of the Board of Directors Chairmanship; John R. Sylvester Appointed New Chairman as Company Prepares for US Commercial Launch
February 15, 2023
Delcath Systems Announces New Drug Application Resubmission for HEPZATO Kit
February 13, 2023
Delcath Systems Announces Updated Results from CHOPIN Phase 1b Trial Published in Cardiovascular and Interventional Radiology
January 16, 2023
Calls in 2023
Decks in 2023
- Investor Presentation (September 2023)
Investor deck · 42 slides · Sep 6, 2023
- Investor Presentation (August 2023)
Investor deck · 42 slides · Aug 15, 2023
- Investor Presentation (March 2023)
Investor deck · 42 slides · Mar 28, 2023
- Investor Presentation (January 2023)
Investor deck · 42 slides · Jan 3, 2023